Big Ideas, Real Impact.
We have established a private sandbox and incubation serving as a centralized commercial interface for selected market-ready cutting-edge healthcare AI startups. We have carefully curated a number of exclusive/priority partnerships with outstanding startups spun off from National University of Singapore (NUS) and leading institutions in the UK, US, and the Netherlands.
These exclusive novel technologies offer real-time, non-invasive diagnostics that are currently unique to the Asian private market, in the following key focus areas including:
01
Preventive Screening
02
Neurological and Sensory Health
03
Musculoskeletal Health
04
Specialized Wellness
Men’s Health
Women’s Health
Current Projects
The Pilot AI Platform is an advanced, self-service digital ecosystem designed to put proactive health management directly into your hands. Engineered for seamless patient accessibility, our platform integrates a powerful suite of clinically driven artificial intelligence technologies, empowering you to screen, monitor, and track critical aspects of your health independently.
Acting as a comprehensive wellness gateway, the Pilot AI Platform connects you to sophisticated AI tools through a single, intuitive interface. Patients can seamlessly access essential screening applications, including AI cardiovascular risk assessment scoring, AI vitals monitoring, and AI hemoglobin scoring. Beyond cardiovascular health, the platform integrates specialized neurological evaluation tools, offering accessible AI testing for Alzheimer’s disease, cognitive impairment, and neurosensory functions.
By transforming complex data into clear insights, the Pilot AI Platform makes premium predictive health technology truly accessible.
PILOT AI Platform
Traditional blood testing is bottlenecked by painful needles and clinic delays, causing over 20% of patients to postpone necessary draws. This pioneering MedTech platform entirely disrupts the industry by bringing screening out of the lab and into the living room.
Using a simple, 60-second camera scan, the software leverages physics-informed deep learning models to perform non-invasive vitals tracking. Through advanced AI lip-color analysis, it estimates hemoglobin, hematocrit, and blood oxygen levels with 95% specificity accuracy—requiring zero blood draw. To ensure absolute safety and accuracy, Pilot Medical Group is anchoring the clinical validation process across our medical centers.
This delivers a highly scalable, high-margin business model targeting the booming decentralized healthcare market. By cutting remote sampling costs and capturing continuous health data, it provides a high-growth asset with immense upside and a clear regulatory roadmap.